A two-year investigation of alleged patent abuses by Swiss pharmaceutical company Novartis has been dropped by the Competition Commission (ComCo) without charges.
The investigations had shown that the Basel-based pharmaceutical company had acted in accordance with antitrust law, the authority announced on Thursday.
ComCo initiated the investigation in September 2022 and also carried out a search at the Novartis headquarters in Basel at the time. The pharmaceutical company had been accused of possibly using a patent for a preparation for the treatment of skin diseases in an unlawful manner to protect itself from competitors.
As part of the investigation, the Competition Commission cooperated with the European Commission.
The investigation has now revealed that Novartis’ conduct was common practice in the area of patent law and also complied with antitrust law, according to the press release. As the indications of abuse have not been confirmed, ComCo is closing the investigation without any consequences.
The European Commission has independently analysed the facts of the case and has come to the same conclusions, the Swiss authority continues.
Translated from German by DeepL/mga
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to [email protected].
More
Swiss ten-year fixed mortgage rates halved since 2022 peak
This content was published on
Rate cuts by the Swiss National Bank have eased conditions for home loans, says online platform Comparis.
Swiss bearded vulture rare win amid global wildlife catastrophe
This content was published on
The reintroduction of bearded vultures in Switzerland is a rare bright spot amid a global wildlife catastrophe in the last 50 years.
This content was published on
The Geneva Science and Diplomacy Anticipator (GESDA) is embarking on a new stage to confront the global public with the scientific challenges of the future.
This content was published on
Valais initially had clearance to shoot one wolf pack, but this has been extended after wolves were found to have killed livestock.
SWI swissinfo.ch – the international service of the Swiss Broadcasting Corporation (SBC).
Since 1999, swissinfo.ch has fulfilled the federal government’s mandate to distribute information about Switzerland internationally, supplementing the online offerings of the radio and television stations of the SBC. Today, the international service is directed above all at an international audience interested in Switzerland, as well as at Swiss citizens living abroad.
In Switzerland, some 156,900 people have Alzheimer’s or some other form of dementia, and this is expected to rise to 315,400 by 2050 according to the organisation Alzheimer Schweiz.
Swiss breast cancer screening quality varies across cantons
This content was published on
Aug 6, 2024
The quality of breast cancer screening programmes in Switzerland varies from canton to canton. However, according to a study published on Tuesday, the results align with the European standard.
Read more: Swiss breast cancer screening quality varies across cantons
More
Swiss army neutralised 280 unexploded ordnances in 2023